TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+4.56%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.67B
AUM Growth
+$41.2M
(+1.6%)
Cap. Flow
-$9.43M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
35.39%
Holding
233
New
11
Increased
50
Reduced
32
Closed
29
Top Buys
| 1 |
AbbVie
ABBV
|
$29.9M |
| 2 |
Illumina
ILMN
|
$20.5M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$18.9M |
| 5 |
Humana
HUM
|
$15.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$42.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
$33.8M |
| 3 |
UnitedHealth
UNH
|
$29.4M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$23.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$20.7M |
Sector Composition
| 1 | Healthcare | 95.21% |
| 2 | Real Estate | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
51
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.1M | 0.49% |
78,784
| – | – |
|
|
52
Thermo Fisher Scientific
TMO
$186B
| $13M | 0.49% |
29,461
-76,564
| -72% | -$33.8M |
|
53
NovoCure
NVCR
$1.37B
| $13M | 0.49% |
116,845
-14,792
| -11% | -$1.65M |
|
54
IQVIA
IQV
$31.9B
| $13M | 0.49% |
82,266
| – | – |
|
55
Bio-Techne
TECH
$8.46B
| $12.8M | 0.48% |
206,840
| – | – |
|
56
Quest Diagnostics
DGX
$20.5B
| $12.6M | 0.47% |
109,659
+88,634
| +422% | +$10.1M |
|
57
Cigna
CI
$81.5B
| $12.1M | 0.45% |
71,241
-8,747
| -11% | -$1.48M |
|
|
ARNA
58
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $12M | 0.45% |
160,637
+72,635
| +83% | +$5.43M |
|
59
Welltower
WELL
$112B
| $11.2M | 0.42% |
203,083
| – | – |
|
60
Acadia Pharmaceuticals
ACAD
$4.26B
| $10.3M | 0.39% |
250,743
| – | – |
|
61
HCA Healthcare
HCA
$98.5B
| $10.2M | 0.38% |
81,933
-1,900
| -2% | -$237K |
|
62
Elevance Health
ELV
$70.6B
| $9.97M | 0.37% |
37,133
-3,109
| -8% | -$835K |
|
63
Baxter International
BAX
$12.5B
| $9.81M | 0.37% |
122,023
| – | – |
|
64
Jazz Pharmaceuticals
JAZZ
$7.86B
| $9.62M | 0.36% |
67,456
| – | – |
|
65
Mettler-Toledo International
MTD
$26.9B
| $9.46M | 0.35% |
9,800
+3,677
| +60% | +$3.55M |
|
|
GRTX
66
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $9.42M | 0.35% |
1,041,845
| – | – |
|
67
Zoetis
ZTS
$67.9B
| $9.35M | 0.35% |
56,521
-24,600
| -30% | -$4.07M |
|
68
Novo Nordisk
NVO
$245B
| $9.3M | 0.35% |
268,010
| – | – |
|
69
Omega Healthcare
OHI
$12.7B
| $9.18M | 0.34% |
306,433
| – | – |
|
70
Ionis Pharmaceuticals
IONS
$9.76B
| $9.17M | 0.34% |
193,201
| – | – |
|
71
Iovance Biotherapeutics
IOVA
$901M
| $8.92M | 0.33% |
271,073
| – | – |
|
|
DOC
72
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.88M | 0.33% |
495,733
| – | – |
|
73
Ventas
VTR
$30.9B
| $8.73M | 0.33% |
208,108
| – | – |
|
74
Fate Therapeutics
FATE
$116M
| $8.69M | 0.33% |
217,462
+31,790
| +17% | +$1.27M |
|
|
ONC
75
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $8.1M | 0.3% |
28,280
-46,704
| -62% | -$13.4M |
|